 John Meshki
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance P | 7 | 2016 | 43 | 0.790 |
Why?
| | Receptors, Neurokinin-1 | 5 | 2013 | 12 | 0.650 |
Why?
| | Cell Membrane | 3 | 2012 | 734 | 0.600 |
Why?
| | p21-Activated Kinases | 1 | 2011 | 15 | 0.370 |
Why?
| | Prostatic Neoplasms | 3 | 2024 | 998 | 0.370 |
Why?
| | Protein Kinase C-epsilon | 2 | 2010 | 26 | 0.360 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 161 | 0.330 |
Why?
| | rho-Associated Kinases | 2 | 2012 | 87 | 0.320 |
Why?
| | Receptors, Purinergic P2 | 2 | 2005 | 23 | 0.270 |
Why?
| | Neutrophils | 4 | 2005 | 1210 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1202 | 0.240 |
Why?
| | Uridine Triphosphate | 2 | 2005 | 12 | 0.230 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 88 | 0.230 |
Why?
| | Myosins | 1 | 2024 | 132 | 0.220 |
Why?
| | Neurokinin-1 Receptor Antagonists | 4 | 2013 | 9 | 0.220 |
Why?
| | Cell Degranulation | 1 | 2003 | 42 | 0.220 |
Why?
| | Phosphorylation | 5 | 2011 | 1713 | 0.210 |
Why?
| | Signal Transduction | 10 | 2013 | 4931 | 0.200 |
Why?
| | HIV-1 | 3 | 2014 | 838 | 0.200 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 247 | 0.200 |
Why?
| | Adenosine Triphosphate | 2 | 2005 | 479 | 0.190 |
Why?
| | Calcium | 8 | 2013 | 1212 | 0.190 |
Why?
| | Cell Line, Tumor | 4 | 2024 | 3186 | 0.150 |
Why?
| | Cell Line | 4 | 2013 | 2784 | 0.150 |
Why?
| | Morpholines | 3 | 2013 | 122 | 0.130 |
Why?
| | Neurotransmitter Agents | 2 | 2014 | 81 | 0.130 |
Why?
| | Apoptosis | 4 | 2010 | 2492 | 0.130 |
Why?
| | Monocytes | 2 | 2016 | 553 | 0.130 |
Why?
| | Protein Kinase C | 2 | 2009 | 262 | 0.130 |
Why?
| | Chemokines | 1 | 2016 | 226 | 0.120 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 59 | 0.110 |
Why?
| | Somatostatin | 1 | 2013 | 56 | 0.100 |
Why?
| | Fibrinogen | 2 | 2004 | 163 | 0.100 |
Why?
| | Antigens, CD | 2 | 2014 | 487 | 0.100 |
Why?
| | Macrophages | 3 | 2016 | 1488 | 0.100 |
Why?
| | Cell Movement | 1 | 2016 | 948 | 0.100 |
Why?
| | Colchicine | 1 | 2011 | 24 | 0.090 |
Why?
| | Receptors, Cell Surface | 1 | 2014 | 381 | 0.090 |
Why?
| | Microscopy, Video | 1 | 2011 | 25 | 0.090 |
Why?
| | Cell-Derived Microparticles | 1 | 2012 | 68 | 0.090 |
Why?
| | Analgesics | 1 | 2013 | 191 | 0.090 |
Why?
| | Blotting, Western | 2 | 2011 | 1206 | 0.090 |
Why?
| | bcl-Associated Death Protein | 1 | 2010 | 10 | 0.090 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 307 | 0.090 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2010 | 149 | 0.090 |
Why?
| | Tubulin | 1 | 2011 | 138 | 0.080 |
Why?
| | Central Nervous System Diseases | 1 | 2010 | 69 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 388 | 0.080 |
Why?
| | Cell Survival | 2 | 2010 | 1076 | 0.080 |
Why?
| | Myosin-Light-Chain Phosphatase | 1 | 2009 | 3 | 0.080 |
Why?
| | Actins | 1 | 2011 | 411 | 0.080 |
Why?
| | Myosin Light Chains | 1 | 2009 | 27 | 0.080 |
Why?
| | Cell Shape | 1 | 2009 | 54 | 0.080 |
Why?
| | Intracellular Space | 1 | 2009 | 69 | 0.080 |
Why?
| | rho GTP-Binding Proteins | 1 | 2009 | 60 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2009 | 426 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2004 | 312 | 0.070 |
Why?
| | HIV Infections | 2 | 2014 | 2730 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2542 | 0.070 |
Why?
| | Receptors, Purinergic P2Y2 | 2 | 2005 | 6 | 0.070 |
Why?
| | Cellular Senescence | 1 | 2009 | 181 | 0.070 |
Why?
| | Cytoplasmic Granules | 2 | 2004 | 78 | 0.070 |
Why?
| | Pancreatic Elastase | 2 | 2004 | 60 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 326 | 0.070 |
Why?
| | Humans | 15 | 2024 | 129625 | 0.060 |
Why?
| | Brain | 2 | 2016 | 2673 | 0.060 |
Why?
| | Chemokine CCL2 | 2 | 2016 | 117 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2013 | 2011 | 0.060 |
Why?
| | Neurons | 1 | 2013 | 1494 | 0.060 |
Why?
| | Nucleotides | 1 | 2005 | 122 | 0.060 |
Why?
| | Anti-HIV Agents | 1 | 2010 | 757 | 0.050 |
Why?
| | Membrane Microdomains | 1 | 2003 | 33 | 0.050 |
Why?
| | Butadienes | 1 | 2003 | 36 | 0.050 |
Why?
| | beta-Cyclodextrins | 1 | 2003 | 27 | 0.050 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2003 | 38 | 0.050 |
Why?
| | Enzyme Inhibitors | 2 | 2004 | 827 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2024 | 481 | 0.050 |
Why?
| | Membrane Lipids | 1 | 2003 | 91 | 0.050 |
Why?
| | Blood-Brain Barrier | 2 | 2016 | 131 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 887 | 0.050 |
Why?
| | Nitriles | 1 | 2003 | 170 | 0.050 |
Why?
| | Imidazoles | 1 | 2003 | 234 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 611 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2003 | 813 | 0.050 |
Why?
| | Indoles | 1 | 2003 | 383 | 0.040 |
Why?
| | Drug Interactions | 2 | 2013 | 395 | 0.040 |
Why?
| | Pyrazoles | 1 | 2003 | 404 | 0.040 |
Why?
| | Pyridines | 1 | 2003 | 478 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2005 | 1336 | 0.040 |
Why?
| | Aging | 1 | 2009 | 1778 | 0.040 |
Why?
| | Up-Regulation | 2 | 2016 | 840 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2016 | 110 | 0.030 |
Why?
| | Microvessels | 1 | 2016 | 82 | 0.030 |
Why?
| | Male | 4 | 2024 | 63670 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2455 | 0.030 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 2 | 2004 | 56 | 0.030 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 11 | 0.030 |
Why?
| | Receptors, Somatostatin | 1 | 2013 | 24 | 0.030 |
Why?
| | Ion Transport | 1 | 2013 | 62 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 102 | 0.030 |
Why?
| | Virus Activation | 1 | 2013 | 88 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2013 | 164 | 0.020 |
Why?
| | Dynamins | 1 | 2012 | 35 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2133 | 0.020 |
Why?
| | Cytosol | 1 | 2012 | 219 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2016 | 749 | 0.020 |
Why?
| | Transfection | 1 | 2013 | 915 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4084 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 261 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2013 | 356 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 698 | 0.020 |
Why?
| | NF-kappa B | 1 | 2013 | 665 | 0.020 |
Why?
| | Fetus | 1 | 2013 | 774 | 0.020 |
Why?
| | Time Factors | 2 | 2012 | 6555 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1465 | 0.020 |
Why?
| | Mice | 1 | 2024 | 16961 | 0.020 |
Why?
| | Caspase 8 | 1 | 2005 | 48 | 0.020 |
Why?
| | Protein Kinase C-alpha | 1 | 2005 | 37 | 0.020 |
Why?
| | Protein Kinase C-delta | 1 | 2005 | 44 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 2021 | 0.010 |
Why?
| | Isoenzymes | 1 | 2005 | 301 | 0.010 |
Why?
| | Macrophage-1 Antigen | 1 | 2004 | 28 | 0.010 |
Why?
| | Androgens | 1 | 2005 | 177 | 0.010 |
Why?
| | Filipin | 1 | 2003 | 3 | 0.010 |
Why?
| | Cyclodextrins | 1 | 2003 | 7 | 0.010 |
Why?
| | CD11b Antigen | 1 | 2003 | 61 | 0.010 |
Why?
| | GPI-Linked Proteins | 1 | 2003 | 68 | 0.010 |
Why?
| | Leukocyte Elastase | 1 | 2003 | 77 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2003 | 152 | 0.010 |
Why?
| | Tyrosine | 1 | 2004 | 223 | 0.010 |
Why?
| | Magnesium | 1 | 2003 | 154 | 0.010 |
Why?
| | Chemotaxis | 1 | 2003 | 129 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 151 | 0.010 |
Why?
| | Female | 2 | 2024 | 68734 | 0.010 |
Why?
| | Models, Genetic | 1 | 2005 | 593 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 184 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 276 | 0.010 |
Why?
| | Animals | 1 | 2024 | 35391 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2003 | 173 | 0.010 |
Why?
| | Interleukin-8 | 1 | 2003 | 264 | 0.010 |
Why?
| | Biomarkers | 1 | 2014 | 3968 | 0.010 |
Why?
| | Oligopeptides | 1 | 2003 | 258 | 0.010 |
Why?
| | Cholesterol | 1 | 2003 | 412 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1724 | 0.010 |
Why?
| | Adult | 1 | 2016 | 35599 | 0.010 |
Why?
|
|
Meshki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|